Floatz logo

ELIAPIXANT

Refractory or Unexplained Chronic Cough

BayerSmall moleculePhase 1Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Refractory or Unexplained Chronic Cough cohort.

Asset / SponsorPhaseRating
MIDAZOLAM
Bayer
Phase 1CC

Same molecule, other indications

ELIAPIXANT is also rated in:

diabetic neuropathyDormant
B
Indicative ·
60 / 100
View asset →
endometriosisDormant
CCC
Indicative ·
55 / 100
View asset →
overactive bladderDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →